Valuation & Litigation Briefing January/February 2023
Welcome to our first issue of Valuation & Litigation Briefing of 2023. In this issue, topics include royalty damages, post acquisition disputes, employment discrimination cases, and crossing the line between permissible and impermissible legal or factual conclusions.
- Vectura Ltd. v. GlaxoSmithKline LLC: Reasonable royalty damages reflect built-in apportionment
- Use a multifaceted approach to tackle post acquisition disputes
- Financial experts play a key role in employment discrimination cases
- Opinion vs. legal conclusion: Has your expert crossed the line?
As always, if you have questions or currently in need of valuation services, please reach out to John F. Maloney, CPA, CFF, CVA, ABAR at 215.675.8364.
DISCLAIMER: The WM Update, WM Wednesday Wisdom, WM Daily Update COVID-19, COVID-19 Business Resources, COVID-19 Client News Alerts and other related communications are intended to provide general information, including information regarding legislative COVID-19 relief measures, as of the date of this communication and may reference information from reputable sources. Although our firm has made every reasonable effort to ensure that the information provided is accurate, we make no warranties, expressed or implied, on the information provided. As legislative efforts are still ongoing, we expect that there may be additional guidance and clarification from regulators that may modify some of the provisions in this communication. Some of those modifications may be significant. As such, be aware that this is not a comprehensive analysis of the subject matter covered and is not intended to provide specific recommendations to you or your business with respect to the matters addressed.